查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球福利导管市场-2022-2029
市场调查报告书
商品编码
1143417

全球福利导管市场-2022-2029

Global Foley Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期间（2022-2029 年），Foley 导管市场预计将以 6.2% 的高复合年增长率增长。

留置式 (Foley) 导管是一种封闭的无菌系统，允许将保留球囊和导管插入尿道或耻骨上，以便通过膀胱引流。 Foley导尿管是最常见的用于从膀胱排出尿液的导尿管之一。这种细的、无菌的、柔性的管子用于各种慢性和急性疾病，包括尿失禁和良性前列腺增生 (BPH)。这些导管仅建议在 30 天内短期使用。

市场动态

由于尿潴留、良性前列腺增生 (BPH)、尿失禁和前列腺癌等泌尿系统疾病的患病率不断上升，全球 Foley 导管市场正在扩大。

此外，全球老年人口数量的增加预计将成为市场增长的驱动力。

尿失禁是普通人群，尤其是老年人的常见疾病，会降低生活质量。世界卫生组织 (WHO) 认为 65 岁以上的人年龄较大，联合国认为 60 岁以上的人年龄较大。世界人口正在迅速老龄化，目前65岁以上人口为7.03亿，预计到2050年这一数字将达到15亿。尿失禁是普通人群，尤其是老年人的常见疾病，会降低生活质量。据说，10-20% 的女性和 77% 的疗养院女性患有尿失禁。

此外，在许多针对老年女性的研究中都观察到了尿失禁，在美国研究中的总体频率为 14%。在欧洲国家进行的一项研究估计，尿失禁的患病率为 37%。根据在亚洲国家进行的调查，老年人尿失禁的患病率在亚洲为 13%，在非洲为 45.3%。在中东国家进行的一项调查报告称，尿失禁的患病率为 52%。因此，全球对 Foley 导管的需求增加。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

与 Foley 导管相关的并发症预计将在预测期内得到抑制。

这个过程很痛苦。插入和拔出润滑不良的导管会在尿道壁和器械表面之间产生摩擦。即使一开始不会感到不舒服，继续使用也会使尿道变窄，导致出血和感染。应特别注意避免尿石症和 CAUTI 的不良影响。此外，不利的税收制度、新兴国家不利的报销做法以及增加的产品故障和召回预计将在预测期内阻碍市场。

行业分析

Foley 导管市场根据各种行业因素（包括未满足的需求、定价分析、供应链分析和监管分析）对市场进行深入分析。

细分分析

预计乳胶部分将在 Foley 导管市场占有最大的市场份额。

乳胶细分市场将在 2021 年占据最大的市场份额。这部分受益，因为由纯乳胶製成的导管更便宜。水凝胶、硅胶和聚四氟乙烯涂层使这些导管柔软、润滑、可靠、高度灵活、嵌入更少、刺激性更小，并且可以提高患者的安全性。预计涂层乳胶导管很快就会有很高的需求，因为它们可以最大限度地减少细菌粘附和包皮。例如，Cardinal Health 生产 Dover 水凝胶涂层乳胶 Foley 导管，以方便插入并保护患者的尿道。因此，增加了对基于乳胶的 Foley 导管的需求。因此，从上述描述来看，市场细分在预测期内占据了最大的市场份额。

竞争格局

Foley 导管市场的主要关键参与者是： B. Braun Melsungen AG、康乐保公司、Teleflex Incorporated、BD、Cardinal Health、美敦力、SunMed、BACTIGUARD 等。

B. Braun Melsangen AG

B.Braun 是一家德国医疗器械和药品製造商。 B.Brown 的产品线由 5,000 种产品组成，其中 95% 是内部製造的。公司的产品组合包括输液、营养和疼痛产品、输液泵和系统、手术器械、缝合材料、髋关节和膝关节植入物、透析机和配件、造口术、消毒和伤口护理产品。它通过五个部门运营：医院护理、Aesculap、B.Brown Avitam、门诊市场 (OPM) 和其他分销。 B.Brown 在 64 个国家/地区开展业务，并在医疗保健行业的 18 个治疗领域开发产品。

产品组合

Urimedcas Foley Neraton：Urimedcas Foley Nelaton 导管是一种分叉的硅胶 Foley 导管，适用于常规膀胱引流。

功效

  • 急性和慢性尿潴留
  • 为因神经系统疾病导致排尿障碍或感觉丧失而影响排尿而排尿困难的患者保持持续排尿。
  • 需要准确测量危重患者的尿量
  • 特定外科手术的围手术期
  • 接受泌尿外科手术或其他泌尿系统附近结构手术的患者
  • 预计会延长手术时间的患者
  • 术中尿量监测的必要性
  • 帮助大小便失禁患者□骨或会阴部的开放性伤口癒合
  • 需要长期制动的患者（如胸腰椎不稳定、骨盆骨折等多发性外伤等）
  • 允许膀胱冲洗/阴道冲洗。
  • 促进节制和保持皮肤完整性（如果保守治疗失败）
  • 根据需要提高临终关怀的舒适度
  • 顽固性尿失禁的管理

全球福利导管市场报告提供对超过 45 个市场数据表和超过 40 个数据的访问。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品类型划分的市场细分
  • 按应用划分的市场细分
  • 按材料划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章 Foley 导管市场 - 市场动态

  • 市场影响因素
  • 驱动程序
    • 尿失禁和 BPH 增加
    • Foley 导管的技术进步
  • 约束因素
    • 严格的产品审批规定
  • 商机
  • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 产品开发
  • 未满足的需求

第 6 章按产品类型

  • 两种方式
  • 三向
  • 四个方向

第 7 章材料

  • 乳胶
  • 硅胶
  • 其他

第 8 章按应用程序

  • 尿失禁
  • 良性前列腺增生 (BPH)
  • 手术
  • 其他

第 9 章，最终用户

  • 医院
  • 长期护理医疗机构
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 12 章公司简介

  • B.Braun Melsungen AG
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Coloplast Corp
  • Teleflex Incorporated
  • BD
  • Cardinal Health
  • Medtronic
  • SunMed
  • BACTIGUARD（*List Is Not Exhaustive）

第13章 DataM

简介目录
Product Code: DMMD1472

Market Overview

Foley Catheter Market is expected to grow at a high CAGR of 6.2% during the forecasting period (2022-2029).

An indwelling (Foley) catheter is a closed sterile system with a retention balloon and a catheter inserted either through the urethra or suprapubically to allow for bladder drainage. Foley catheters are one of the most common urinary catheters used for draining urine from the bladder. These thin, sterile, flexible tubes are used for various chronic and acute conditions, including urinary incontinence and benign prostatic hyperplasia (BPH). These catheters are recommended only for short-term use, for less than 30 days.

Market Dynamics

The global foley catheters market is growing owing to the rising prevalence of urological diseases, such as urinary retention, benign prostate hyperplasia (BPH), urinary incontinence, and prostate cancer.

The increasing elderly patient population globally is expected to drive market growth.

Urinary incontinence is a common condition in the general population, particularly the older adult population, which reduces the quality of life. The World Health Organization (WHO) considers persons 65 or older to be older adults, while the United Nations considers those 60 years or older to be older adults. The world's population is quickly aging, with 703 million individuals over the age of 65 presently, and this figure is expected to rise to 1.5 billion by 2050. Urine incontinence is a prevalent disorder in the general population, particularly among older people, and it lowers the quality of life. Ten to twenty percent of all women and 77% of women in nursing homes have urinary incontinence.

Moreover, Urinary incontinence has been observed in much research among older women, with an overall frequency of 14% in US studies. The prevalence of urine incontinence has been estimated to be 37% in research conducted in European countries. In research conducted across Asia, the prevalence of urine incontinence in older persons was 13% in Asia and 45.3% in Africa. The prevalence of urinary incontinence was reported to be 52% in a study conducted in Middle Eastern countries. Therefore, it has increased the demand for foley catheters worldwide. Thus, from the above statements, the market is expected to drive in the forecast period.

Complications associated with the foley catheter are expected to get hampered in the forecast period.

The procedure is painful. It entails inserting and removing insufficiently lubricated catheters, causing friction between the urethral walls and the device's surface. These may not be unpleasant at first, but continued usage may cause urethral constriction, resulting in bleeding and infection. Extra caution is essential to avoid the negative effects of UTIs and CAUTIs. Moreover, unfavorable tax policies, unfavorable reimbursement practices in developing nations, and increased product failures and recalls are the factors the market is expected to hamper in the forecast period.

Industry Analysis

The foley catheter market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

Latex segment is expected to hold the largest market share in the foley catheter market.

The latex segment accounted for the largest market share in 2021. The segment is benefiting because catheters made of pure latex are not expensive. These catheters have hydrogel, silicone, and Teflon coatings that make them soft, lubricious, reliable, and highly flexible; they provide increased patient safety with less encrustation and irritation. The ability of coated latex catheters to minimize bacterial adhesion and encrustation is predicted to increase demand shortly. For instance, Cardinal Health manufactures the Dover Hydrogel Coated Latex Foley Catheter to make insertion easier and to protect the patient's urethra. Therefore, it has increased the demand for latex-based foley catheters. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the foley catheter market are: B. Braun Melsungen AG, Coloplast Corp, Teleflex Incorporated, BD, Cardinal Health, Medtronic, SunMed and BACTIGUARD, among others.

B. Braun Melsungen AG:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Urimed Cath Foley Nelaton: The Urimed Cath Foley Nelaton catheter is a two-way silicone Foley catheter indicated for routine bladder drainage.

Indication:

  • Acute and chronic urinary retention
  • Maintain a continuous outflow of urine for patients with voiding difficulties as a result of neurological disorders that cause paralysis or loss of sensation affecting urination,
  • Need for accurate measurement of urinary output in critically ill patients
  • Perioperative for selected surgical procedures
  • Patients undergoing urological surgery or other surgery on contiguous structures of the genitourinary tract
  • Anticipated prolonged duration of surgery
  • Need for intra-operative monitoring of urinary output
  • To assist in healing of open sacral or perineal wounds in incontinent patients
  • Patient requires long-term immobilization (e.g. potentially unstable thoracic or lumbar spine, multiple traumatic injuries such as pelvic fractures
  • To allow bladder irrigation/lavage
  • To facilitate continence and maintain skin integrity (when conservative treatment methods have been unsuccessful
  • To improve comfort for end of life care if needed
  • Management of intractable incontinence.

The global foley catheter market report would provide an access to an approx. 45+ market data table, 40+ figures.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Material
  • 3.4. Market Snippet by End-User
  • 3.5. Market Snippet by Region

4. Foley Catheters Market-Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Rising prevalence of urinary incontinence & BPH
    • 4.2.2. Technological Advancements in Foley Catheters
  • 4.3. Restraints
    • 4.3.1. Stringent regulations for product approvals
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Product developments
  • 5.6. Unmet Needs

6. By Product Type

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  • 6.3. Market Attractiveness Index, By Product Type Segment
    • 6.3.1. Two-way*
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 6.3.2. Three-way
    • 6.3.3. Four-way

7. By Material

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
  • 7.3. Market Attractiveness Index, By Material Segment
    • 7.3.1. Latex*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Silicone
    • 7.3.3. Others

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Urinary Incontinence*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Benign Prostatic Hyperplasia (BPH)
    • 8.3.3. Surgery
    • 8.3.4. Others

9. By End-User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
  • 9.3. Market Attractiveness Index, By End-User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Long-term Care Facilities
    • 9.3.3. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Coloplast Corp
  • 12.3. Teleflex Incorporated
  • 12.4. BD
  • 12.5. Cardinal Health
  • 12.6. Medtronic
  • 12.7. SunMed
  • 12.8. BACTIGUARD (*List Is Not Exhaustive)

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us